Johnson & Johnson

JNJ US Health Care Pharmaceuticals
S&P 500 Dow Jones
$265.58
-0.29%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.49.
  • Comfortable interest cover: operating profit covers interest about 33.6 times.
  • Return on equity is healthy at 31.5%.
  • Return on capital employed is healthy at 22.2%.
  • Net profit margin is strong at 28.5%.
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
5.5

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Piotroski F-ScoreWeak
3 / 8

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 8 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap$640.02B
Current Price$ 265.58
High / Low$ 281.07 / 173.33
Stock P/E30.774042
Book Value$ 34.82
Dividend Yield1.97%
ROCE22.17%
ROE31.54%
Debt to Equity0.49
Current Ratio1.03
P/B Ratio7.526924
EPS$ 11.03
Debt$41.44B
PAT Margin28.46%
Cash PAT$34.31B
ICR33.55
Educational data only. Not a recommendation to buy, sell or hold any security.